Home/Pipeline/Fizurex

Fizurex

Anal Fissures

Pre-clinicalActive

Key Facts

Indication
Anal Fissures
Phase
Pre-clinical
Status
Active
Company

About Steel Therapeutics

Steel Therapeutics is a novel pharmaceutical company with a unique strategy of taking established, efficacious therapies from the compounding pharmacy space and developing them into FDA-approved products with optimized delivery. Its first candidate, Fizurex™, is a disposable wipe formulation of nifedipine and lidocaine for anal fissures, aiming to replace compounded creams. The founding team combines deep expertise in pharmacy compounding, pharmaceutical commercialization, medical device regulation, and finance, positioning the company to bridge a significant gap between unregulated compounding and standardized, scalable pharmaceutical products.

View full company profile

Therapeutic Areas